القيمة السوقية تغيير تاريخ
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Arrowhead Research USD 9.7B 920M 2026-05
Astellas Pharma JPY 4.56T 770.92B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Celltrion KRW 42.71T 908.1B 2026-05
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Divis Laboratories Ltd INR 1.58T 118.27B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 14.34B 3.44B 2026-05
Halozyme Therapeutics USD 8.56B 905M 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Neurocrine Biosciences USD 15.15B 1.9B 2026-05
Novartis USD 232.75B 75B 2026-05
OPKO Health USD 967.3M 263.06M 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pfizer USD 147.4B 6.42B 2026-05
Pharma Mar EUR 1.79B 211.96M 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Qiagen NV USD 6.43B 1.85B 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.16B 123M 2026-05
Sartorius EUR 14.25B 2.16B 2026-03
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05
Zealand Pharma A/S 33.35B 448.34M 2025-12